Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade

Open Access

Policy Platform The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

About the Authors

Rianna Stefanakis

* E-mail: rstefanakis@bvgh.org

Affiliation BIO Ventures for Global Health, San Francisco, California, United States of America

Andrew S. Robertson

Elizabeth L. Ponder

Melinda Moree

The authors have declared that no competing interests exist.

Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Neglected tropical diseases
Is the Subject Area "Neglected tropical diseases" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Malaria
Is the Subject Area "Malaria" applicable to this article?

Thanks for your feedback.
Phase I clinical investigation
Is the Subject Area "Phase I clinical investigation" applicable to this article?

Thanks for your feedback.
Phase II clinical investigation
Is the Subject Area "Phase II clinical investigation" applicable to this article?

Thanks for your feedback.